1791 
(2) CONTENTS.—The report required under 
paragraph (1) shall— 
(A) identify any substantial changes made 
in the strategy during the preceding calendar 
year; 
(B) describe the progress made in imple-
menting the strategy; 
(C) identify the indicators used to establish 
benchmarks and measure results over time, as 
well as the mechanisms for reporting such re-
sults in an open and transparent manner; 
(D) contain a transparent, open, and de-
tailed accounting of expenditures by relevant 
Federal departments and agencies to implement 
the strategy, including, to the extent prac-
ticable, for each Federal department and agen-
cy, the statutory source of expenditures, 
amounts expended, partners, targeted popu-
lations, and types of activities supported; 
(E) describe how the strategy leverages 
other United States global health and develop-
ment assistance programs; 
(F) assess efforts to coordinate United 
States global health security programs, activi-
ties, and initiatives with key stakeholders; 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 01791
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
1792 
(G) incorporate a plan for regularly review-
ing and updating strategies, partnerships, and 
programs and sharing lessons learned with a 
wide range of stakeholders, including key stake-
holders, in an open, transparent manner; and 
(H) describe the progress achieved and 
challenges concerning the United States Gov-
ernment’s ability to advance the Global Health 
Security Agenda across priority countries, in-
cluding data disaggregated by priority country 
using indicators that are consistent on a year- 
to-year basis and recommendations to resolve, 
mitigate, or otherwise address the challenges 
identified therein. 
(e) FORM.—The strategy required under subsection 
(a) and the report required under subsection (d) shall be 
submitted in unclassified form but may contain a classi-
fied annex. 
SEC. 191510. COMPLIANCE WITH THE FOREIGN AID TRANS-
PARENCY AND ACCOUNTABILITY ACT OF 
2016. 
Section 2(3) of the Foreign Aid Transparency and 
Accountability Act of 2016 (Public Law 114–191; 22 
U.S.C. 2394c note) is amended— 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 01792
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
1793 
(1) in subparagraph (C), by striking ‘‘and’’ at 
the end; 
(2) in subparagraph (D), by striking the period 
at the end and inserting ‘‘; and’’; and 
(3) by adding at the end the following: 
‘‘(E) the Global Health Security Act of 
2020.’’. 
SEC. 191511. DEFINITIONS. 
In this subtitle: 
(1) APPROPRIATE
CONGRESSIONAL
COMMIT-
TEES.—The term ‘‘appropriate congressional com-
mittees’’ means— 
(A) the Committee on Foreign Affairs and 
the Committee on Appropriations of the House 
of Representatives; and 
(B) the Committee on Foreign Relations 
and the Committee on Appropriations of the 
Senate. 
(2) GLOBAL
HEALTH
SECURITY.—The term 
‘‘global health security’’ means activities supporting 
epidemic and pandemic preparedness and capabili-
ties at the country and global levels in order to mini-
mize vulnerability to acute public health events that 
can endanger the health of populations across geo-
graphical regions and international boundaries. 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 01793
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
1794 
SEC. 191512. SUNSET. 
This subtitle (other than section 191507), and the 
amendments made by this subtitle, shall cease to be effec-
tive on December 31, 2024. 
Subtitle C—Securing America 
From Epidemics Act 
SEC. 191513. FINDINGS. 
Congress finds the following: 
(1) Due to increasing population and popu-
lation density, human mobility, and ecological 
change, emerging infectious diseases pose a real and 
growing threat to global health security. 
(2) While vaccines can be the most effective 
tools to protect against infectious disease, the ab-
sence of vaccines for a new or emerging infectious 
disease with epidemic potential is a major health se-
curity threat globally, posing catastrophic potential 
human and economic costs. 
(3) The 1918 influenza pandemic infected 
500,000,000 people, or about one-third of the 
world’s 
population 
at 
the 
time, 
and 
killed 
50,000,000 people—more than died in the First 
World War. 
(4) The economic cost of an outbreak can be 
devastating. The estimated global cost today, should 
an outbreak of the scale of the 1918 influenza pan-
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 01794
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS
1795 
demic strike, is 5 percent of global gross domestic 
product. 
(5) Even regional outbreaks can have enormous 
human costs and substantially disrupt the global 
economy and cripple regional economies. The 2014 
Ebola outbreak in West Africa killed more than 
11,000 and cost $2,800,000,000 in losses in the af-
fected countries alone. 
(6) The ongoing novel coronavirus outbreak re-
flects the pressing need for quick and effective vac-
cine and countermeasure development. 
(7) While the need for vaccines to address 
emerging epidemic threats is acute, markets to drive 
the necessary development of vaccines to address 
them—a complex and expensive undertaking—are 
very often critically absent. Also absent are mecha-
nisms to ensure access to those vaccines by those 
who need them when they need them. 
(8) To address this global vulnerability and the 
deficit of political commitment, institutional capac-
ity, and funding, in 2017, several countries and pri-
vate partners launched the Coalition for Epidemic 
Preparedness Innovations (CEPI). CEPI’s mission 
is to stimulate, finance, and coordinate development 
of vaccines for high-priority, epidemic-potential 
VerDate Sep 11 2014 
21:01 May 12, 2020
Jkt 099200
PO 00000
Frm 01795
Fmt 6652
Sfmt 6201
E:\BILLS\H6800.IH
H6800
tkelley on DSKBCP9HB2PROD with BILLS